CClinicalTrials.gg
CompletedNCT04747743Updated May 27, 2022

Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners

An observational study in Temporomandibular Joint Disorders and Bruxism, sponsored by Future University in Egypt. Completed at 1 site in Egypt. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-05-27.

Sponsored by Future University in Egypt · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
170
Ages
20 Years to 60 Years
Sex
All
01

Study summary

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

Read the detailed description

Skeletal muscle relaxants (SMR) are a diverse group of medications that are not chemically related like other drug classes and work through a variety of mechanisms. The term "muscle relaxant" is used to refer to two major therapeutic groups: neuromuscular blockers and spasmolytic. Some of them are working mainly through the central nervous system; they have many adverse effects such as sedation and dizziness that may limit their use.

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

02

Conditions studied

03

In context

Temporomandibular Joint Disorders

609 studies on the registry are indexed under Temporomandibular Joint Disorders; 160 are open to participants now.

This study's enrollment of 170 is above the median of 90 across 165 observational studies indexed under Temporomandibular Joint Disorders.

Browse Temporomandibular Joint Disorders studies →

Lead sponsor

Future University in Egypt is the lead sponsor of 97 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

dental practitioners in Egypt (professionals both academic and nonacademic).

Inclusion criteria

  • academic dental practitioners in Egypt
  • nonacademic dental practitioners in Egypt

Exclusion criteria

Exclusion Criteria:

  • Age less than 20 or more than 60
  • Non-dental
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
170 participants (actual)
Patient registry
No

Groups and cohorts

  • Egyptian dental practitioners

    170 dental practitioners in Egypt (professionals both academic and nonacademic).

    Other: a self structured questionnaire

Interventions

  • Othera self structured questionnaire

    A self structured questionnaire to assess knowledge of skeletal muscle use in dental practice

06

What researchers measure

Primary outcomes

  1. Dental practitioner's knowledge about muscle relaxants indications

    Extent of dental practitioner's knowledge about muscle relaxants indications in practice

    Time frame: 1 month

  2. importance of direct communication between dental practitioners and pharmacists in order to detect the communication barriers and how to overcome those barriers.

    To assess and improve the communication between pharmacist- dentist regarding Skeletal muscle relaxant

    Time frame: 1 month

Secondary outcomes

  1. Dental practitioner's knowledge about muscle relaxants doses

    Extent of dental practitioner's knowledge about muscle relaxants different doses in practice

    Time frame: 1 month

  2. Dental practitioner's knowledge about muscle relaxants side effects

    Extent of dental practitioner's knowledge about muscle relaxants possible side effects

    Time frame: 1 month

07

Study locations

1 site
  • Future University in egypt
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04747743
Lead sponsor
Future University in Egypt
Collaborators
Ain Shams University, British University In Egypt, Cairo University
Responsible party
Doaa Mohamed Salah ElDin Diab ELBohy (Associate professor, Future University in Egypt) — Principal investigator
First posted
Feb 10, 2021
Start date
Feb 10, 2021
Primary completion
Mar 10, 2021
Completion
Mar 15, 2021
Last update
May 27, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion